Filgrastim ratiopharm regulatory update

EMEA approved an MAA from ratiopharm for Filgrastim ratiopharm to treat neutropenia. The granulocyte colony stimulating factor (G-CSF) is a biosimilar of Neupogen filgrastim from Amgen Inc. (NASDAQ:...